A company plans to make a human therapeutic protein on an industrial scale. Its project report lists three activities:
- Engineering an E. coli strain so that it produces large amounts of the protein.
- Designing a bioreactor and fixing the temperature, pH and aeration at which the engineered strain works best.
- Separating the protein from the culture broth and purifying it until it is fit for human use.
(a) Name the critical research area of biotechnology to which each activity belongs.
(b) A second team proposes to replace the engineered E. coli with a pure enzyme that carries out the same conversion. To which of the three research areas does this change belong? Give a reason.
